Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Celebrating Success: Putting Your Business in the Spotlight

It is very much recognised that success in Life Sciences, bringing innovative new treatments and diagnostics to patients, is a team game. Best in class Innovation, collaboration, services, and infrastructure are all pivotal to addressing the complex challenges of finding solutions to unmet medical need. The One Nucleus Annual Awards seek to recognise excellence across the whole Life Science ecosystem given the vital role each stakeholder plays.

Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers

Amsterdam, the Netherlands and Sydney, Australia 30 September 2024 - Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, announces a collaboration with CMRI, a leading Australian pediatric medical research institute, and Omico, an organization uniting over 50 world-class cancer institutes in Australia and New Zealand.

Research Study from Indivumed Therapeutics Reveals a Path for the Discovery of New Targets and Development of Novel Cancer Therapies

HAMBURG, GERMANY - A new study led by precision oncology pioneers Indivumed Therapeutics reveals significant changes in the molecular characteristics of tumor samples within as little as 10 minutes after surgical removal. The findings underline the importance of rapid snap freezing of tissue samples to reliably capture cancer biology and reveal novel drug targets.

Microscopy data analysis: machine learning and the BioImage Archive 2025

This virtual course will show how public bioimaging data resources, centred around the BioImage Archive, enable and enhance machine learning based image analysis. The content will explore a variety of data types including electron and light microscopy and miscellaneous or multi-modal imaging data at the cell and tissue scale. Participants will cover contemporary biological image analysis with an emphasis on machine learning methods, as well as how to access and use images from databases.

Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseases

• Programmable, tunable, stable and specific gene silencing has been demonstrated across multiple target genes and multiple cell types
• PoC achieved with concomitant silencing of more than one gene
• Industrialisation of platform processes delivering significant increase in throughput
• Strategic in-house focus on development of pipeline of programmable advanced therapies in oncology and genetic disease

International Men's Day Talks and Workshop

Join us for a networking lunch followed by four inspiring talks from life science leaders and a wellbeing workshop.

Speakers

Steve Martin PhD, Vice President and Head, GSK

Cesare Cejas PhD, Co Founder, MFX

Andrew Stewart, Director of Communications, LifeArc

Ian Parnham PhD, Skills Programme Lead, Cell and Gene Therapy Catapult

Workshop Leads

James Kusena PhD, Vice President of Operations, MFX

Andrew Parsons PhD, Health, Wellness & Executive Coach. Emotional Freedom Techniques. Business Psychologist. Innovator. Author.

EHS & Lab Assistant Shipping & Sample Administrator

The Role:
We are seeking a dedicated EHS & Lab Assistant, Shipping & Sample Administrator to join our team onsite in Cambridge, UK, five days a week. In this dynamic role, you will provide vital support across various functions, including Environmental Health and Safety (EHS), facilities, lab operations, shipping, stockroom, and site housekeeping. You will play a key role in supporting our scientists and facilities, ensuring safety protocols are upheld, shipments are managed efficiently, and the lab environment remains organized and well-stocked.

Coulter Partners Successfully Places Chief Development Officer in the Us for Uk Biotech Company Cellcentric

London, September 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based.

Subscribe to